Silo Pharma, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Silo Pharma, Inc. (Nasdaq: SILO) on June 1, 2026. The report details a material corporate action involving a reverse stock split of the Company's common stock.
Key Financial Metrics
The filing does not provide specific financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. The report focuses exclusively on the structural change to the Company's capitalization.
Material Changes
- Reverse Stock Split: A 1-for-15 reverse stock split was effected on June 1, 2026, becoming effective at 4:01 p.m. Eastern Time on June 2, 2026.
- Trading Resumption: Common stock began trading on a split-adjusted basis on June 3, 2026, under the existing symbol "SILO" with a new CUSIP number (82711P 300).
- Authorized Shares: The Company's authorized common shares were proportionately reduced to 6,666,667 shares.
- Equity Adjustments: Exercise prices and share counts for outstanding stock options, warrants, and equity incentive plans were proportionately adjusted.
- Fractional Shares: No fractional shares were issued; holdings were rounded up to the next whole share.
Guidance, Outlook, and Risks
The filing does not contain management commentary on future financial guidance, operational outlook, or specific risk factors beyond the standard incorporation of the Certificate of Change. The Company noted that active registration statements (Forms S-1 and S-3) have been automatically amended to reflect the reduced number of undistributed shares covered by those statements.
Key Facts for Investor Verification
- Verify the new CUSIP number (82711P 300) for trading and settlement purposes.
- Confirm the adjusted number of shares held in brokerage accounts following the 1-for-15 consolidation.
- Review the updated terms of any outstanding stock options or warrants held, as exercise prices and share quantities have been adjusted.
- Check the Company's active registration statements to confirm the updated share availability for future offerings.